Latest Insider Transactions at Qcr Holdings Inc (QCRH)
This section provides a real-time view of insider transactions for Qcr Holdings Inc (QCRH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of QCR HOLDINGS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of QCR HOLDINGS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 09
2023
|
Todd A Gipple President, CFO, COO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,006
+7.38%
|
$105,090
$15.65 P/Share
|
|
Mar 09
2023
|
James M. Field Director |
BUY
Open market or private purchase
|
Direct |
1,000
+15.28%
|
$47,000
$47.49 P/Share
|
|
Mar 02
2023
|
Kurt A Gibson President/CEO CSB |
BUY
Exercise of conversion of derivative security
|
Direct |
217
+4.66%
|
$11,501
$53.08 P/Share
|
|
Mar 01
2023
|
Kurt A Gibson President/CEO CSB |
BUY
Exercise of conversion of derivative security
|
Direct |
529
+4.17%
|
$28,037
$53.31 P/Share
|
|
Mar 01
2023
|
Anne E Howard SVP, Dir Of Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
279
+2.03%
|
$14,787
$53.25 P/Share
|
|
Mar 01
2023
|
Monte C Mc New President & CEO, SFC |
BUY
Exercise of conversion of derivative security
|
Direct |
573
+8.94%
|
$30,369
$53.31 P/Share
|
|
Mar 01
2023
|
Brent R Cobb Director |
BUY
Grant, award, or other acquisition
|
Direct |
516
+1.95%
|
$27,348
$53.31 P/Share
|
|
Mar 01
2023
|
James M. Field Director |
BUY
Grant, award, or other acquisition
|
Direct |
516
+10.2%
|
$27,348
$53.31 P/Share
|
|
Mar 01
2023
|
John F Griesemer Director |
BUY
Grant, award, or other acquisition
|
Direct |
516
+50.0%
|
$27,348
$53.31 P/Share
|
|
Mar 01
2023
|
Mark C Kilmer Director |
BUY
Grant, award, or other acquisition
|
Direct |
516
+2.44%
|
$27,348
$53.31 P/Share
|
|
Mar 01
2023
|
Elizabeth S Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
516
+22.03%
|
$27,348
$53.31 P/Share
|
|
Mar 01
2023
|
Donna J. Sorensen Director |
BUY
Grant, award, or other acquisition
|
Direct |
441
+2.96%
|
$23,373
$53.31 P/Share
|
|
Mar 01
2023
|
Marie Z. Ziegler Director |
BUY
Grant, award, or other acquisition
|
Direct |
591
+1.96%
|
$31,323
$53.31 P/Share
|
|
Mar 01
2023
|
Mary Kay Bates Director |
BUY
Grant, award, or other acquisition
|
Direct |
441
+22.22%
|
$23,373
$53.31 P/Share
|
|
Mar 01
2023
|
John Paul E Besong Director |
BUY
Grant, award, or other acquisition
|
Direct |
441
+16.08%
|
$23,373
$53.31 P/Share
|
|
Feb 24
2023
|
John H Anderson CEO QCBT |
SELL
Open market or private sale
|
Direct |
1,389
-36.9%
|
$73,617
$53.65 P/Share
|
|
Feb 24
2023
|
John H Anderson CEO QCBT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,389
+26.96%
|
$58,338
$42.75 P/Share
|
|
Jan 19
2023
|
Marie Z. Ziegler Director |
BUY
Open market or private purchase
|
Direct |
134
+0.46%
|
$6,432
$48.64 P/Share
|
|
Dec 16
2022
|
Larry J Helling CEO, QCRH & CRBT |
BUY
Open market or private purchase
|
Direct |
1,000
+1.14%
|
$47,000
$47.81 P/Share
|
|
Dec 15
2022
|
Elizabeth S Jacobs Director |
BUY
Open market or private purchase
|
Direct |
214
+14.04%
|
$10,058
$47.22 P/Share
|
|
Dec 09
2022
|
John H Anderson CEO QCBT |
BUY
Open market or private purchase
|
Indirect |
1,069
+2.72%
|
$52,381
$49.53 P/Share
|
|
Nov 07
2022
|
James M. Field Director |
BUY
Open market or private purchase
|
Direct |
1,000
+19.89%
|
$49,000
$49.94 P/Share
|
|
Nov 07
2022
|
Brent R Cobb Director |
BUY
Open market or private purchase
|
Direct |
4,000
+13.6%
|
$196,000
$49.85 P/Share
|
|
Nov 07
2022
|
Elizabeth S Jacobs Director |
BUY
Open market or private purchase
|
Direct |
200
+15.43%
|
$9,800
$49.5 P/Share
|
|
Nov 07
2022
|
John F Griesemer Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+4.06%
|
$48,000
$48.15 P/Share
|
|
Nov 03
2022
|
John F Griesemer Director |
BUY
Open market or private purchase
|
Indirect |
4,500
+21.98%
|
$216,000
$48.16 P/Share
|
|
Oct 20
2022
|
Marie Z. Ziegler Director |
BUY
Open market or private purchase
|
Direct |
118
+0.41%
|
$6,490
$55.31 P/Share
|
|
Jul 21
2022
|
Marie Z. Ziegler Director |
BUY
Open market or private purchase
|
Direct |
117
+0.41%
|
$6,552
$56.1 P/Share
|
|
Apr 21
2022
|
Marie Z. Ziegler Director |
BUY
Open market or private purchase
|
Direct |
112
+0.39%
|
$6,496
$58.11 P/Share
|
|
Apr 01
2022
|
John F Griesemer Director |
BUY
Grant, award, or other acquisition
|
Indirect |
75,588
+50.0%
|
$4,232,928
$56.26 P/Share
|
|
Apr 01
2022
|
John F Griesemer Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,599
+50.0%
|
$89,544
$56.26 P/Share
|
|
Mar 02
2022
|
Anne E Howard SVP, Dir Of Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
91
+3.0%
|
$5,005
$55.96 P/Share
|
|
Mar 02
2022
|
Dana L Nichols EVP, Chief Lending Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
213
+5.71%
|
$11,715
$55.96 P/Share
|
|
Mar 02
2022
|
John H Anderson CEO QCBT |
SELL
Open market or private sale
|
Direct |
214
-8.27%
|
$11,984
$56.0 P/Share
|
|
Mar 01
2022
|
Patrick Baird Director |
BUY
Grant, award, or other acquisition
|
Direct |
344
+0.62%
|
$18,232
$53.87 P/Share
|
|
Mar 01
2022
|
Mary Kay Bates Director |
BUY
Grant, award, or other acquisition
|
Direct |
344
+23.77%
|
$18,232
$53.87 P/Share
|
|
Mar 01
2022
|
John Paul E Besong Director |
BUY
Grant, award, or other acquisition
|
Direct |
344
+15.6%
|
$18,232
$53.87 P/Share
|
|
Mar 01
2022
|
Brent R Cobb Director |
BUY
Grant, award, or other acquisition
|
Direct |
419
+1.92%
|
$22,207
$53.87 P/Share
|
|
Mar 01
2022
|
James M. Field Director |
BUY
Grant, award, or other acquisition
|
Direct |
419
+12.16%
|
$22,207
$53.87 P/Share
|
|
Mar 01
2022
|
Elizabeth S Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
419
+31.86%
|
$22,207
$53.87 P/Share
|
|
Mar 01
2022
|
Mark C Kilmer Director |
BUY
Grant, award, or other acquisition
|
Direct |
419
+2.04%
|
$22,207
$53.87 P/Share
|
|
Mar 01
2022
|
Donna J. Sorensen Director |
BUY
Grant, award, or other acquisition
|
Direct |
419
+2.91%
|
$22,207
$53.87 P/Share
|
|
Mar 01
2022
|
Marie Z. Ziegler Director |
BUY
Grant, award, or other acquisition
|
Direct |
494
+1.7%
|
$26,182
$53.87 P/Share
|
|
Mar 01
2022
|
Anne E Howard SVP, Dir Of Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
219
+2.51%
|
$11,607
$53.87 P/Share
|
|
Mar 01
2022
|
Dana L Nichols EVP, Chief Lending Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
481
+4.78%
|
$25,493
$53.87 P/Share
|
|
Jan 20
2022
|
Marie Z. Ziegler Director |
BUY
Open market or private purchase
|
Direct |
108
+0.38%
|
$6,480
$60.15 P/Share
|
|
Dec 29
2021
|
Dana L Nichols EVP, Chief Lending Officer |
SELL
Open market or private sale
|
Direct |
500
-15.05%
|
$28,000
$56.7 P/Share
|
|
Dec 29
2021
|
Dana L Nichols EVP, Chief Lending Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+13.08%
|
$4,500
$9.3 P/Share
|
|
Dec 27
2021
|
Larry J Helling CEO, QCRH & CRBT |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-6.72%
|
$84,336
$56.15 P/Share
|
|
Dec 27
2021
|
Larry J Helling CEO, QCRH & CRBT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,597
+13.83%
|
$32,373
$9.3 P/Share
|